New MRI technique could sharpen surgery decisions for epilepsy patients

NCT ID NCT06483061

Recruiting now Knowledge-focused Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a special MRI method using ferumoxytol, an iron-based contrast agent, to get clearer images of tiny blood vessels in the brain's memory center (hippocampus) in people with temporal lobe epilepsy. Researchers aim to see if these images can help predict who will benefit most from epilepsy surgery. The study involves 50 adults, including healthy volunteers and epilepsy patients with a specific brain finding called hippocampal sclerosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY, TEMPORAL LOBE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hippocampal sclerosis of aging temporal lobe epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPILEPSY, TEMPORAL LOBE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Peter S. Allen MRI Unit
RECRUITING

Edmonton, Alberta, T6G 2R3, Canada

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••